We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
2022 ERS/ESC PAH Guidelines on Echocardiography
Jean M. Elwing, MD
2022 ERS/ESC PH Guidelines on Diagnosis
2022 ERS/ESC PAH Guidelines on Treatment
Essential Aspects of the New ERS/ESC Treatment Guidelines: Patients Without Comorbidities
Richard N. Channick, MD
Implications of Aggressive Therapy in ‘PAH Without Comorbidities’
Rajan Saggar, MD
Essential Aspects of the New ERS/ESC Treatment Guidelines: Patients With Comorbidities
Implications of Aggressive in ‘PAH with comorbidities’ Therapy: What Does That Mean?
How Should Cardiopulmonary Comorbidities Influence PH Treatment Strategy?
Richard Krasuski, MD
Case: Using the 2022 ESC/ERS Treatment Algorithm in Older Male Patient with Cardiopulmonary Comorbidities
Hot Topics from the New ERS/ESC PH Guidelines: Focus on Treatment
Ioana Preston, MD
Treatment Approaches to ILD-PH
Oksana A. Shlobin, MD
Sudarshan Rajagopal, MD, PhD
Risk Assessment in PAH
What’s the Consensus on Cardiorenal Protection for CKD in T2D?
Tessa Laubscher, MBChB, CCFP, FCFP
George L. Bakris, MD, FAHA, FASN
Mikhail Kosiborod, MD
Applying Evidence to Practice: What Can We Learn from Recent Clinical Trials of IV Iron Use in HF?
Piotr Ponikowski, MD, PhD, FESC, FHFA
Robert J. Mentz, MD, FHFSA, FACC, FAHA
Closing the Gap to Care: Assessing CAD and Improving Patient Outcomes with Revascularization
Adam DeVore, MD
Lauren Barron, MD
Navin Kapur, MD
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education